Clinical Trial Update: Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating venous thromboembolism prophylaxis in medically ill patients completed; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2012-06-27